Stock comparison
AbbVie Inc. is 2.7x more valuable than ABBOTT LABORATORIES by market capitalization ($440.14 B vs $163.95 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
AbbVie Inc. is 2.7x more valuable than ABBOTT LABORATORIES by market capitalization ($440.14 B vs $163.95 B).
Market value leader
ABBV
AbbVie Inc. is 2.7x more valuable than ABBOTT LABORATORIES by market capitalization ($440.14 B vs $163.95 B).
Revenue leader
ABBV
ABT: $44.33B vs ABBV: $61.16B.
Profit leader
ABT
ABT: $6.52B vs ABBV: $4.23B.
Margin leader
ABT
ABT: 14.7% vs ABBV: 6.9% net margin.
| Metric | ABT | ABBV |
|---|---|---|
| Market cap | $163.95 B | $440.14 B |
| US-listed rank | #97 | #25 |
| Revenue (latest FY) | $44.33B | $61.16B |
| Net income (latest FY) | $6.52B | $4.23B |
| Net margin | 14.7% | 6.9% |
| P/E (trailing FY) | 25.1x | 104.2x |
| SEC filings | 1,001 | 1,008 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AbbVie Inc. is 2.7x more valuable than ABBOTT LABORATORIES by market capitalization ($440.14 B vs $163.95 B).
In their latest fiscal years, ABBOTT LABORATORIES reported $44.33B in revenue while AbbVie Inc. reported $61.16B.
Full pages: ABBOTT LABORATORIES and AbbVie Inc., or browse the full rankings.